The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Maxygen Inc. (MAXY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
A biotech stock that you'll be glad you bought

Oct 12, 2009 07:04 PM GMT
Gekko
Return Risk
+6.40% HIGH
Sr. Associate

Fundamental Analysis  

This stock is a rare bird. It's a biotech company with a real product and real earnings. They have no long-term debt and a lot of cash. The P/E under 4. Insiders own about a quarter of the company. They have a discipliined growth strategy, using joint ventures with larger,, better-capitalized partners in order to share costs and risks.

MAXY:  This call was made on 10/12/09 @ $6.55
Rating:   Positive   $6.55 (10/12/09)
Gain/Loss:   -15.88% in 53 days
Target:   $8.00 (+22.14%) in > one year


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
PG The Procter & Gamble Company
WM Washington Mutual Inc
ETFC E*Trade Financial Corp
EBAY eBay Inc
POT Potash Corp. of Saskatchewan Inc.
AMD Advanced Micro Devices Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Maxygen Inc. (MAXY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by Walter Thatcher
Symbol SP Sentiment Rating Return Since
PFBI N/A Positive -11.59% 09/23/09
SKBI N/A Positive +68.04% 08/24/09
SWHC Positive -6.89% 04/02/09
CSH Positive -7.10% 10/31/08
CHBT N/A Negative -48.28% 10/08/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch